Not just another Naturopath but your one stop serious shop to heal heart, body, mind. Programmes designed to address the underlying root causes holistically.
From strength to strength.. that is what you want to see in companies that are investing in your health. Long term security and growth.
Principal COO at Zinzino APAC (Australia, Hong Kong, China, New Zealand & Philippines)
ZINZINO AB (PUBL.): INTERIM REPORT THIRD QUARTER 2024 CONTINUED STRONG GROWTH IN THE THIRD QUARTER🔥🔥🔥 Revenues in the third quarter of 2024 amounted to SEK 532.8 (436.9) million, corresponding to 22% (25%) growth compared to the corresponding period last year. In local currencies, revenues increased by 24% compared to the third quarter of the previous year. EBITDA profit amounted to SEK 63.0 (71.2) million and the EBITDA margin was 11.8% (16.3%). The EBITDA margin was compared to a very strong third quarter last year and the change was mainly due to the marginally weaker gross profit for the quarter because of increased raw material prices and normalized distributor compensation. In addition, increased sales costs linked to acquisitions and expansion, combined with currency translation effects, had a negative impact of SEK -4.2 (3.9) million on EBITDA for the quarter. During the quarter, the company expanded its establishment in France following strong sales growth linked to the acquisition of assets of Xelliss. After the end of the quarter, the new product Collagen Boozt was launched as well as the Canary Islands achieved full market status. This put the Islands on an equal footing with mainland Spain and other European markets. Accumulated total revenue for Q1-Q3 amounted to SEK 1,494.3 (1,238.5) million, corresponding to growth of 21% (22%), accumulated EBITDA of SEK 177.8 (169.3) million and an EBITDA margin of 11.9% (13.7%) #ZinzinoAPAC
